-The Hindu Icann, the global authority dealing with domain names, is hastening the threat of monopolisation on the internet through its new scheme to sell generic words L’Oréal has applied for the top level domain (TLD) .beauty to the Internet Corporation for Assigned Names and Numbers (Icann), the global authority dealing with domain names on the Internet. TLDs are what we see on the right side of the dot in domain names...

-The Hindu Building ‘capitalism with Indian characteristics’ means decisions cannot ignore concerns of voters and communities As the economy slows down and the rupee wilts, Manmohan Singh has bitten the ‘reforms’ bullet with both eyes on the credit rating agencies whose negative reports have done much to dampen the ‘animal spirits’ of investors, foreign and native. Last November, when the Congress party made a push to introduce foreign direct investment in multi-brand retail,...

-PTI Contract labourers working in factories of component suppliers to Maruti Suzuki could bear the brunt of the lockout at the Manesar plant of India's largest carmaker. Working on wafer thin margins amid stiff competition, many of the component suppliers which have been already feeling the heat due to an overall slowdown in the automotive market, are considering to reduce their workforce. "If there is prolonged lockout at Maruti's Manesar plant, there is no...

-The Hindu In the summer of 2011, production at Maruti Suzuki’s Manesar plant ground to a halt, as workers agitated to set up a union independent of the Maruti Udyog Kamdar Union that represented workers at the company’s plant at Gurgaon. The strikes and lockouts eventually dragged on till the fall, and cost the company approximately $500 million in lost production. On Wednesday, nine months after the company finally agreed to recognise...

-Live Mint Natco Pharma Ltd, which has started selling a generic version of Bayer AG’s patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm, plans to use the so-called compulsory licensing route to try and win the right to copy more patented drugs, said vice-chairman and chief executive officer Rajeev Nannapaneni. The Hyderabad-based company has already identified the patented drugs for which it will...